CHENGDU XENOMIX BIOTECHNOLOGY CO LTD

Overview

CHENGDU XENOMIX BIOTECHNOLOGY CO LTD is an active pharmaceutical ingredient (API) supplier with 2 active FDA Type II Drug Master Files, covering HUMAN UMBILICAL CORD MESENCHYMAL STEM CELL-DERIVED EXOSOMES; NONTOXIC DIPHTHERIA TOXIN MUTANT CRM197.

API / Drug Master Files

CHENGDU XENOMIX BIOTECHNOLOGY CO LTD holds 2 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• HUMAN UMBILICAL CORD MESENCHYMAL STEM CELL-DERIVED EXOSOMESActive2025-08-06
• NONTOXIC DIPHTHERIA TOXIN MUTANT CRM197Active2022-12-09

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CHENGDU XENOMIX BIOTECHNOLOGY CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.